Edison, NJ -- (SBWire) -- 01/24/2019 --Summary
Neuroimmunology is expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in neurogenetics, and potential of these drugs that can contribute to targeted therapy. Pipeline drugs targeting a number of neurology indications are being developed; however, the most common ones are Alzheimer's disease (AD) and Multiple Sclerosis (MS).
Companies Mentioned in the Report
AB Science SA
Actelion Pharmaceuticals Ltd.
AZTherapies Inc.
Biogen Inc.
Celgene Corp.
Novartis AG
F. Hoffmann-La Roche AG
Genetech Inc.
Grifols SA
TG Therapeutics Inc.
TauRX Therapeutics Ltd
Click to get Neuroimmunology Drug Development Market Research Sample PDF Copy Here @: https://www.htfmarketreport.com/sample-report/1569990-neuroimmunology-drug-development
This report provides an overview of current clinical and product development trends for neuroimmunology within the 8MM (France, Germany, Italy, Spain, UK, US, Japan, China), including analysis of the most common targets and molecule types that are being evaluated among the current pipeline drugs, focus on product development in indications such as AD and MS, and unmet needs within neuroimmunology. Clinical trials analyze ongoing trials by different phases of development and by sponsor type, as well as trends in combination therapy trials.
Scope
This report combines primary research from a cross-specialty panel of neurology experts with in-house analyst expertise to provide an assessment of the development landscape. Components of the slide deck include primary and secondary research -
- Quotes from 10 key opinion leaders (3 US, 5 EU, 1 Japan, 1 China)
- Summary of neuroimmunology product definitions and classifications
- Overview of common targets and molecule types among current pipeline drugs, with focus on product development in AD and MS
- Trends in ongoing clinical trials in neuroimmunology based on sponsor type, and phase of development
- Call-outs of key information and details
- Insight from GlobalData's specialist neurology analysts.
Enquire for customization in Report @ https://www.htfmarketreport.com/enquiry-before-buy/1569990-neuroimmunology-drug-development
Reasons to buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the neuroimmunology market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the neuroimmunology market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Buy Full Copy Neuroimmunology Drug Development Report 2018 @ https://www.htfmarketreport.com/reports/1569990-neuroimmunology-drug-development
Table of Contents
1. Introduction
2. Executive Summary 7
3. Neuroimmunology Product Definition and Classification 10
4. Overview of Common Targets in Neuroimmunology 12
5. Assessment of Marketed Neuroimmunology Products 17
6. Assessment of Pipeline Neuroimmunology Products 21
7. Indication Specific Overview: Multiple Sclerosis 37
8. Indication Specific Overview: Alzheimer's Disease 46
9. Trends in Clinical Trials of Neuroimmunology Drugs 57
10. Appendix 69
Buy this research @ https://www.htfmarketreport.com/buy-now?format=1&report=1569990
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Neuroimmunology Drug Development by Focusing Product, Overview, Pipeline Drugs, Key Players
The "Neuroimmunology Drug Development", report combines primary research from a cross-specialty panel of neurology experts with in-house analyst expertise to provide an assessment of the development landscape.